Human Metabolome Technologies Balance Sheet Health
Financial Health criteria checks 5/6
Human Metabolome Technologies has a total shareholder equity of ¥1.8B and total debt of ¥200.0M, which brings its debt-to-equity ratio to 11%. Its total assets and total liabilities are ¥2.3B and ¥480.0M respectively. Human Metabolome Technologies's EBIT is ¥245.0M making its interest coverage ratio 122.5. It has cash and short-term investments of ¥1.5B.
Key information
11.0%
Debt to equity ratio
JP¥200.00m
Debt
| Interest coverage ratio | 122.5x |
| Cash | JP¥1.46b |
| Equity | JP¥1.81b |
| Total liabilities | JP¥480.00m |
| Total assets | JP¥2.29b |
Recent financial health updates
Recent updates
Human Metabolome Technologies' (TSE:6090) Weak Earnings May Only Reveal A Part Of The Whole Picture
Oct 03
Human Metabolome Technologies, Inc.'s (TSE:6090) Business And Shares Still Trailing The Market
Aug 06Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00
Jun 07Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00
May 22Human Metabolome Technologies (TSE:6090) Is Paying Out A Larger Dividend Than Last Year
Apr 06Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00
Mar 23Human Metabolome Technologies (TSE:6090) Will Pay A Larger Dividend Than Last Year At ¥15.00
Feb 26Financial Position Analysis
Short Term Liabilities: 6090's short term assets (¥1.8B) exceed its short term liabilities (¥458.0M).
Long Term Liabilities: 6090's short term assets (¥1.8B) exceed its long term liabilities (¥22.0M).
Debt to Equity History and Analysis
Debt Level: 6090 has more cash than its total debt.
Reducing Debt: 6090's debt to equity ratio has increased from 0% to 11% over the past 5 years.
Debt Coverage: 6090's debt is well covered by operating cash flow (118%).
Interest Coverage: 6090's interest payments on its debt are well covered by EBIT (122.5x coverage).